表紙
市場調查報告書
商品編碼
1028194

醫藥品批發·流通的全球市場(2021年∼2025年)

Global Pharmaceuticals Wholesale and Distribution Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

醫藥品批發·流通的市場規模在2021年∼2025年的預測期間內,預計將以7.93%的年複合成長率推移,並成長到5,487億美元。

本報告提供醫藥品批發·流通市場相關之本報告提供整體分析,市場規模與預測,趨勢,涵括成長要素,課題,以及約25位供應商的供應商分析。

該市場成長的主要因素有全球性醫藥品銷售額的擴大,以及政府配合措施的增加。

本報告提供醫藥品批發·流通市場調查,提供市場概要,市場規模,市場預測,客戶形勢,各藥品類型·各地區的分析,再加上業者情勢和供應商分析等資訊。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2020年
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各藥品類型市場區隔

  • 市場區隔
  • 品牌藥:市場規模與預測(2020年∼2025年)
  • 學名藥:市場規模與預測(2020年∼2025年)
  • 各藥品類型的市場機會

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2020年∼2025年)
  • 亞洲:市場規模與預測(2020年∼2025年)
  • 歐洲:市場規模與預測(2020年∼2025年)
  • 其他地區:市場規模與預測(2020年∼2025年)
  • 主要國家
  • 各地區形勢市場機會
  • 市場成長促進因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Alfresa Holdings Corp.
  • AmerisourceBergen Corp.
  • Cardinal Health Inc.
  • Dakota Drug Inc.
  • Fosun International Ltd.
  • McKesson Corp.
  • Medline Industries Inc.
  • Owens & Minor Inc.
  • PHOENIX Pharma SE
  • SUZUKEN Co. Ltd.

附錄

目錄
Product Code: IRTNTR70680

Technavio has been monitoring the pharmaceuticals wholesale and distribution market and it is poised to grow by $ 548.70 bn during 2021-2025, progressing at a CAGR of 7.93% during the forecast period. Our report on the pharmaceuticals wholesale and distribution market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing global pharmaceutical sales and increasing government initiatives. In addition, growing global pharmaceutical sales is anticipated to boost the growth of the market as well.

The pharmaceuticals wholesale and distribution market analysis includes the type segment and geographic landscape.

Technavio's pharmaceuticals wholesale and distribution market is segmented as below:

By Type

  • Branded drugs
  • Generic drugs

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • ROW

This study identifies the rising seaborne pharmaceutical transportationas one of the prime reasons driving the pharmaceuticals wholesale and distribution market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on pharmaceuticals wholesale and distribution market covers the following areas:

  • Pharmaceuticals wholesale and distribution market sizing
  • Pharmaceuticals wholesale and distribution market forecast
  • Pharmaceuticals wholesale and distribution market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceuticals wholesale and distribution market vendors that include Alfresa Holdings Corp., AmerisourceBergen Corp., Cardinal Health Inc., Dakota Drug Inc., Fosun International Ltd., McKesson Corp., Medline Industries Inc., Owens & Minor Inc., PHOENIX Pharma SE, and SUZUKEN Co. Ltd. Also, the pharmaceuticals wholesale and distribution market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Types of Drugs
    • Market segments
    • Branded drugs - Market size and forecast 2020-2025
    • Generic drugs - Market size and forecast 2020-2025
    • Market opportunity by Types of Drugs
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Alfresa Holdings Corp.
    • AmerisourceBergen Corp.
    • Cardinal Health Inc.
    • Dakota Drug Inc.
    • Fosun International Ltd.
    • McKesson Corp.
    • Medline Industries Inc.
    • Owens & Minor Inc.
    • PHOENIX Pharma SE
    • SUZUKEN Co. Ltd.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ billion)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Other1 - Market share 2020-2025 (%)
  • 22: Comparison by Other1
  • 23: Branded drugs - Market size and forecast 2020-2025 ($ billion)
  • 24: Branded drugs - Year-over-year growth 2020-2025 (%)
  • 25: Generic drugs - Market size and forecast 2020-2025 ($ billion)
  • 26: Generic drugs - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Other1
  • 28: Customer landscape
  • 29: Market share By Geographical Landscape 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ billion)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Asia - Market size and forecast 2020-2025 ($ billion)
  • 34: Asia - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ billion)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ billion)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity By Geographical Landscape ($ billion)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Alfresa Holdings Corp. - Overview
  • 48: Alfresa Holdings Corp. - Business segments
  • 49: Alfresa Holdings Corp. - Key offerings
  • 50: Alfresa Holdings Corp. - Key customers
  • 51: Alfresa Holdings Corp. - Segment focus
  • 52: AmerisourceBergen Corp. - Overview
  • 53: AmerisourceBergen Corp. - Business segments
  • 54: AmerisourceBergen Corp. - Key offerings
  • 55: AmerisourceBergen Corp. - Key customers
  • 56: AmerisourceBergen Corp. - Segment focus
  • 57: Cardinal Health Inc. - Overview
  • 58: Cardinal Health Inc. - Business segments
  • 59: Cardinal Health Inc. - Key offerings
  • 60: Cardinal Health Inc. - Key customers
  • 61: Cardinal Health Inc. - Segment focus
  • 62: Dakota Drug Inc. - Overview
  • 63: Dakota Drug Inc. - Product and service
  • 64: Dakota Drug Inc. - Key offerings
  • 65: Dakota Drug Inc. - Key customers
  • 66: Dakota Drug Inc. - Segment focus
  • 67: Fosun International Ltd. - Overview
  • 68: Fosun International Ltd. - Business segments
  • 69: Fosun International Ltd. - Key offerings
  • 70: Fosun International Ltd. - Key customers
  • 71: Fosun International Ltd. - Segment focus
  • 72: McKesson Corp. - Overview
  • 73: McKesson Corp. - Business segments
  • 74: McKesson Corp. - Key offerings
  • 75: McKesson Corp. - Key customers
  • 76: McKesson Corp. - Segment focus
  • 77: Medline Industries Inc. - Overview
  • 78: Medline Industries Inc. - Product and service
  • 79: Medline Industries Inc. - Key offerings
  • 80: Medline Industries Inc. - Key customers
  • 81: Medline Industries Inc. - Segment focus
  • 82: Owens & Minor Inc. - Overview
  • 83: Owens & Minor Inc. - Business segments
  • 84: Owens & Minor Inc. - Key offerings
  • 85: Owens & Minor Inc. - Key customers
  • 86: Owens & Minor Inc. - Segment focus
  • 87: PHOENIX Pharma SE - Overview
  • 88: PHOENIX Pharma SE - Business segments
  • 89: PHOENIX Pharma SE - Key offerings
  • 90: PHOENIX Pharma SE - Key customers
  • 91: PHOENIX Pharma SE - Segment focus
  • 92: SUZUKEN Co. Ltd. - Overview
  • 93: SUZUKEN Co. Ltd. - Business segments
  • 94: SUZUKEN Co. Ltd. - Key offerings
  • 95: SUZUKEN Co. Ltd. - Key customers
  • 96: SUZUKEN Co. Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations